Ha Noi CPC1 Pharmaceutical JSC
UUPCOM:DTP59,000.00
VND
0.00
(0.00%)
Ha Noi CPC1 Pharmaceutical JSC
UPCOM:DTP
(Unlisted Public Company Market)
Recent
price
59,000.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Ha Noi CPC1 Pharmaceutical Joint Stock Company (UPCoM: DTP) is a Vietnam-based pharmaceutical manufacturing enterprise specializing in the research, development, production, and distribution of advanced sterile pharmaceutical formulations, biotherapeutics, and healthcare products. Founded in 2009 and headquartered in Thuong Tin District, Hanoi, Vietnam, the company operates high-tech manufacturing facilities compliant with GMP-WHO standards in the Ha Binh Phuong Industrial Zone. Ha Noi CPC1 Pharmaceutical Joint Stock Company provides a diverse portfolio of over 500 pharmaceutical and healthcare products organized into key therapeutic and form-specific categories: Blow-Fill-Seal (BFS) sterile single-dose formulations, including preservative-free ophthalmic eye drops, plastic ampoule injections, respiratory nebulizer solutions, oral ampoules, and sterile distilled water; Bag-on-Valve (BOV) and continuous aerosol spray systems, including nasal sprays, oral-throat sprays, and dermatological sprays; biotherapeutics and probiotic preparations, featuring spore-based liquid suspensions such as Progermila (Bacillus clausii); sterile injectables and intravenous infusion therapies; oral liquid formulations, including syrups, drops, and pediatric suspensions; solid and semisolid dosage forms, comprising soft gelatin capsules, suppositories, and topical creams and gels; nutritional supplements, vitamins, and medical devices; and comprehensive contract manufacturing, Original Equipment Manufacturer (OEM), and Original Design Manufacturer (ODM) services providing formulation development, aseptic packaging, and regulatory support for institutional clients. In recent company developments, Ha Noi CPC1 Pharmaceutical Joint Stock Company has expanded its international export footprint across more than 40 countries spanning Southeast Asia, East Asia, the Middle East, and Latin America, including shipments to Peru, Chile, the United Arab Emirates, Oman, Hong Kong, and South Korea. The company has augmented its industrial capacity through continuous investments in imported European automated Blow-Fill-Seal lines and advanced aseptic filling technologies to scale its specialized ophthalmic and respiratory portfolios. Furthermore, the company has diversified its therapeutic pipeline toward high-barrier single-dose medical products, reinforced corporate governance and compliance mechanisms in alignment with global standardizations, and maintained active capital management through regular cash and stock dividend distributions to shareholders.